ichor
链接:https://ichor.bio/
Ichorbio 成立于2019年,位于英国牛津。是一家专注于体内研究用抗体的生物技术公司。Ichorbio 旨在成为研究级生物仿制药和体内抗体的最大供应商,通过提供价格合理的高质量产品,支持科研工作。
产品线:
1、体内抗体:Ichorbio 提供多种体内抗体,包括抗小鼠体内抗体,这些产品分为低内毒素(Low endotoxin)和超低内毒素(Ultra-low endotoxin)两种系列,以满足不同的研究需求。
2、同型对照抗体:公司还提供同型对照抗体,这对于研究中排除非特异性结合的干扰至关重要。
-批量人 IgG1 (IB1) 同型对照
-用于体内的叙利亚仓鼠 IgG 同型对照 – 低内毒素
–用于体内的小鼠 IgM 同型对照 – 低内毒素
-亚美尼亚仓鼠 IgG (PIP) 同种型对照用于体内 – 低内毒素
3、科研用生物仿制药抗体:Ichorbio 生产科研用途的生物仿制药抗体,这些抗体仅用于研究,不用于诊断或治疗用途。
–西妥昔单抗生物类似药 – GAALIE 研究级
-利妥昔单抗生物类似药N297A研究级
4、RMP1-14与Fc沉默抗体:公司还提供包括RMP1-14在内的特定抗体产品,以及Fc沉默抗体,这些产品在免疫学研究中可能有特殊用途。
RMP1-14抗体
–小鼠 Anti-Mouse PD-1 (RMP1-14) 重组抗体 LALAPG
-小鼠 Anti-Mouse PD-1 (RMP1-14) 重组抗体 D265A
-小鼠PD-1(RMP1-14)重组抗体
-抗PD-1(RMP1-14)
-抗PD-1(RMP1-14)5mg/ml
Fc沉默抗体
-小鼠 Anti-Mouse PD-1 (29F.1A12) 重组抗体 (LALAPG)
-小鼠 Anti-Mouse PD-L1 (10F.9G2) 重组抗体 (LALAPG)
-小鼠 Anti-Mouse PD-1 (RMP1-14) 重组抗体 LALAPG
-利妥昔单抗生物类似药N297A研究级
-小鼠 Anti-Mouse PD-1 (RMP1-14) 重组抗体 D265A
-小鼠 IgG1 (IB5) 同型对照品 D265A 用于体内
5、其他产品:Ichorbio 的产品线还包括HLA-DR抗体、HLA-DQ抗体等,这些抗体在免疫学和肿瘤学研究中可能有应用。
产品优势:
内毒素水平:Ichorbio 提供的抗体产品具有低内毒素含量,这有助于减少体内实验中潜在的内毒素相关的副作用。
高纯度与低聚集率:公司产品的纯度高,抗体聚集率低,这有助于提高实验的准确性和重复性。
生产条件:Ichorbio 的生产条件符合高标准,确保了产品的质量和稳定性。
Ichorbio热卖产品
货号 | 品名 | 规格 | 品牌 |
ICH5056-20mg | Abciximab Biosimilar – Research Grade | 20mg | ichor |
ICH5056-1mg | Abciximab Biosimilar – Research Grade | 1mg | ichor |
ICH5056-10mg | Abciximab Biosimilar – Research Grade | 10mg | ichor |
ICH1114-5mg | Anti-Mouse RANKL In Vivo Antibody – Low Endotoxin (IK22/5) | 5mg | ichor |
ICH1024-5mg | Bulk anti-Human HLA-DP antibody (B7/21) | 5mg | ichor |
ICH1025-5mg | Bulk anti-Human HLA-DQ antibody (1a3) | 5mg | ichor |
ICH5025-0.5mg | Blinatumomab Biosimilar – Research Grade [ICH5025] | 0.5mg | ichor |
ICH2255-25mg | Bulk Human IgG2 Isotype Control (IB2) | 25mg | ichor |
ICH4002-1mg | Alemtuzumab Biosimilar – Research Grade | 1mg | ichor |
ICH2254SELF-5MG | Bulk Human IgG1 Isotype Control (IB1) SELF | 5mg | ichor |
ICH2254LALA-5mg | Human IgG1 Isotype Control (IB1) LALA | 5mg | ichor |
ICH2254-5mg | Bulk Human IgG1 Isotype Control (IB1) | 5mg | ichor |
ICH2254-100mg | Bulk Human IgG1 Isotype Control (IB1) [ICH2254] | 100mg | ichor |
ICH2250-5mg | Mouse IgG2b Isotype Control for In Vivo – Low Endotoxin (MPC-11) | 5mg | ichor |
ICH2249UL-5mg | Mouse IgG3 Isotype Control for In Vivo – Ultra Low Endotoxin (MG3-35) [ICH2249UL] | 5mg | ichor |
ICH2246-5mg | Rat IgG1 Isotype Control for In Vivo – Low Endotoxin (GL113) | 5mg | ichor |
ICH2244 | Rat IgG2a In Vivo Isotype Control – Low Endotoxin (1-1) | 5mg | ichor |
ICH2243-25mg | Rat IgG2b In Vivo Isotype Control – Low Endotoxin (1-2) | 25mg | ichor |
ICH1206-25mg | Anti-Mouse IL-21R In Vivo Antibody (4A9) – Low Endotoxin | 25mg | ichor |
ICH1204-25mg | Anti-Mouse CXCL9 In Vivo Antibody (MIG-2F5-5) – Low Endotoxin | 25mg | ichor |
ICH1196-25mg | Anti-Mouse CD134 In Vivo Antibody (OX-86) – Low Endotoxin | 25mg | ichor |
ICH1183-100mg | Mouse anti-Mouse PD-L1 antibody (10F.9G2) [ICH1183] | 100mg | ichor |
ICH1172-25mg | Bulk anti-Human CCR5 antibody (HEK/1/85a/7a) | 25mg | ichor |
ICH1156-5mg | Bulk anti-Human CD40 antibody (G28.5) [ICH1156] | 5mg | ichor |
ICH1155-100mg | Bulk anti-Human CD45 antibody (BC8) [ICH1155] | 100mg | ichor |
ICH1137-50mg | Anti-Mouse TNFR2 In Vivo Antibody – Low Endotoxin (TR75-54.7) | 50mg | ichor |
ICH5013-50mg | Girentuximab Biosimilar – Research Grade [ICH5013] | 50mg | ichor |
ICH5082-0.1mg | Caplacizumab Biosimilar – Research Grade | 0.1mg | ichor |
ICH5070-1mg | Enfortumab Biosimilar – Research Grade | 1mg | ichor |
ICH5065-5mg | BMS986016 – Research Grade | 5mg | ichor |
ICH5064-1mg | Guselkumab Biosimilar – Research Grade | 1mg | ichor |
ICH5039-10mg | Polatuzumab vedotin Biosimilar – Research Grade | 10mg | ichor |
ICH5025-5mg | Blinatumomab Biosimilar – Research Grade | 5mg | ichor |
ICH5025-1mg | Blinatumomab Biosimilar – Research Grade [ICH5025] | 1mg | ichor |
ICH5025-0.1mg | Blinatumomab Biosimilar – Research Grade | 0.1mg | ichor |
ICH5023-1mg | Theralizumab Biosimilar – Research Grade | 1mg | ichor |
ICH2256-25mg | Bulk Human IgG3 Isotype Control (IB3) | 25mg | ichor |
ICH5002-0.1mg | Toripalimab Biosimilar – Research Grade [ICH5026] | 0.1mg | ichor |
ICH4031-20mg | Ranibizumab Biosimilar – Research Grade | 20mg | ichor |
ICH4014-20mg | Ado-trastuzumab emtansine Biosimilar – Research Grade | 20mg | ichor |
ICH4014-0.1mg | Ado-trastuzumab emtansine Biosimilar – Research Grade | 0.1mg | ichor |
ICH4005-20mg | Eculizumab Biosimilar – Research Grade | 20mg | ichor |
ICH1132-50mg | Anti-Mouse PD-1 In Vivo Antibody – Low Endotoxin (RMP1-14) | 50mg | ichor |
ICH2258D265A-5MG | Mouse IgG1 Isotype Control for In Vivo (IB5) D265A | 5MG | ichor |
ICH2257-25mg | Bulk Human IgG4 Isotype Control (IB4) | 25mg | ichor |
ICH1023-25mg | Bulk anti-Human MHC Class I antibody (W6/32) | 25mg | ichor |
ICH1086-100mg | Anti-Mouse PD-L1 In Vivo Antibody – Low Endotoxin (10F.9G2) | 100mg | ichor |
ICH1084-5mg | Anti-Mouse CTLA-4 In Vivo Antibody – Low Endotoxin (9H10) | 5mg | ichor |
ICH1076-5mg | Anti-Mouse CD172a In Vivo Antibody – Low Endotoxin (P84) | 5mg | ichor |
ICH1075-5mg | Anti-Mouse CD155 In Vivo Antibody – Low Endotoxin (4.24) | 5mg | ichor |